Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial

L. A. Morrow; M. Hompesch; S. J. Jacober; S. Leng Choi; Y. Qu; V. P. Sinha

doi:10.1111/dom.12691

Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12691 ◽

2016 ◽

Vol 18 (11) ◽

pp. 1065-1071 ◽

Cited By ~ 7

Author(s):

L. A. Morrow ◽

M. Hompesch ◽

S. J. Jacober ◽

S. Leng Choi ◽

Y. Qu ◽

...

Keyword(s):

Type 1 Diabetes ◽

Steady State ◽

Insulin Glargine ◽

Basal Insulin ◽

Crossover Trial ◽

Randomized Crossover Trial ◽

Long Acting

Download Full-text

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study

Diabetes Care ◽

10.2337/dc12-0067 ◽

2012 ◽

Vol 36 (3) ◽

pp. 522-528 ◽

Cited By ~ 71

Author(s):

J. Rosenstock ◽

R. M. Bergenstal ◽

T. C. Blevins ◽

L. A. Morrow ◽

M. J. Prince ◽

...

Keyword(s):

Weight Loss ◽

Type 1 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Crossover Study ◽

Basal Insulin ◽

The Novel ◽

Long Acting ◽

Randomized Crossover Study

Download Full-text

Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.

Endocrine Practice ◽

10.1016/j.eprac.2021.11.001 ◽

2021 ◽

Author(s):

Wendy S. Lane ◽

Stephen L. Weinrib ◽

Michael J. Lawrence ◽

Benjamin C. Lane ◽

Ryan T. Jarrett

Keyword(s):

Type 1 Diabetes ◽

Glycemic Control ◽

Basal Insulin ◽

Crossover Trial ◽

Insulin Pump ◽

Insulin Degludec ◽

Single Center ◽

Open Label ◽

Randomized Crossover Trial

Download Full-text

A Comparison of Two Hybrid Closed-Loop Systems in Adolescents and Young Adults with Type 1 Diabetes: A Multicenter Randomized Crossover Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3696846 ◽

2020 ◽

Author(s):

Richard M. Bergenstal ◽

Revital Nimri ◽

Roy W. Beck ◽

Amy Criego ◽

Lori Laffel ◽

...

Keyword(s):

Type 1 Diabetes ◽

Young Adults ◽

Closed Loop ◽

Crossover Trial ◽

Adolescents And Young Adults ◽

Closed Loop Systems ◽

Randomized Crossover Trial ◽

Two Hybrid

Download Full-text

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial

Endocrinology Diabetes & Metabolism ◽

10.1002/edm2.213 ◽

2021 ◽

Author(s):

Naba Al‐Sari ◽

Signe Schmidt ◽

Tommi Suvitaival ◽

Min Kim ◽

Kajetan Trošt ◽

...

Keyword(s):

Type 1 Diabetes ◽

Crossover Trial ◽

Carbohydrate Diet ◽

Post Hoc Analysis ◽

Low Carbohydrate Diet ◽

Randomized Crossover Trial ◽

Low Carbohydrate ◽

Post Hoc

Download Full-text

Acylated-based long-acting insulin analogues: Is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2014.10.001 ◽

2014 ◽

Vol 40 (6) ◽

pp. 483-484 ◽

Cited By ~ 1

Author(s):

L. Monnier ◽

C. Colette ◽

D. Owens

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Analogues ◽

Insulin Degludec ◽

Insulin Antibody ◽

Daily Insulin ◽

Acting Insulin ◽

Long Acting

Download Full-text

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Diabetes Care ◽

10.2337/dc18-0706 ◽

2018 ◽

Vol 42 (1) ◽

pp. 85-92 ◽

Cited By ~ 12

Author(s):

Francesca Porcellati ◽

Paola Lucidi ◽

Paola Candeloro ◽

Patrizia Cioli ◽

Anna Marinelli Andreoli ◽

...

Keyword(s):

Type 1 Diabetes ◽

Steady State ◽

Insulin Glargine ◽

Hepatic Glucose Production ◽

Glucose Production ◽

Hepatic Glucose

Download Full-text

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13534 ◽

2018 ◽

Vol 21 (2) ◽

pp. 349-356 ◽

Cited By ~ 6

Author(s):

Othmar Moser ◽

Max L. Eckstein ◽

Alexander Mueller ◽

Philipp Birnbaumer ◽

Felix Aberer ◽

...

Keyword(s):

Type 1 Diabetes ◽

Crossover Trial ◽

Insulin Degludec ◽

Randomized Crossover Trial

Download Full-text

The relationship between meal carbohydrate quantity and the insulin to carbohydrate ratio required to maintain glycaemia is non‐linear in young people with type 1 diabetes : A randomized crossover trial

Diabetic Medicine ◽

10.1111/dme.14675 ◽

2021 ◽

Author(s):

Natalie M Cordon ◽

Carmel EM Smart ◽

Grant J Smith ◽

Elizabeth A Davis ◽

Timothy W Jones ◽

...

Keyword(s):

Type 1 Diabetes ◽

Young People ◽

Crossover Trial ◽

Randomized Crossover Trial ◽

Non Linear ◽

The Relationship

Download Full-text

Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes

2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\Systems Biology (BGRS\SB) ◽

10.1109/csgb.2018.8544728 ◽

2018 ◽

Author(s):

V.V. Klimontov ◽

E.A. Koroleva ◽

O.N. Fazullina

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Glucose Variability ◽

Insulin Analogues ◽

Hospitalized Patients

Download Full-text

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group

Diabetes Care ◽

10.2337/diacare.23.8.1137 ◽

2000 ◽

Vol 23 (8) ◽

pp. 1137-1142 ◽

Cited By ~ 142

Author(s):

J. Rosenstock ◽

G. Park ◽

J. Zimmerman

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Nph Insulin ◽

Daily Insulin

Download Full-text